Median returns three months post IPO 2024 performance (the green line in Chart 5) were much better than the last two years (purple and pink lines). Importantly, 2024 IPOs as a group have so far held ...
The first Israeli IPO on . Nasdaq. in 2025 is expected to take place soon, when tech company Odysight.ai (OTC: ODYS) will ...
Cystic fibrosis-focused Sionna Therapeutics is joining the Nasdaq this morning with an upsized public offering, while obesity ...
FBS Global Limited (NASDAQ: FBGL), a Singapore-based green building contractor, launched its initial public offering (IPO) on ...
Sionna late Thursday said it is selling nearly 10.6 million shares at $18 apiece in the IPO, compared with prior plans to offer about 8.82 million shares at between $16 and $18 each. The Waltham, Mass ...
Michigan-based community bank Northpointe Bancshares (NPB) is the first U.S. lender to hold an initial public offering (IPO) this year.
Clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis—Sionna Therapeutics (SION) priced its upsized initial public offering of ...
EPWK Holdings (NASDAQ: EPWK) launched its initial public offering (IPO) at a price of $4.10 per share, which is consistent ...
Northpointe Bancshares is targeting a valuation of up to $595 million in its initial public offering in the United States, ...
The FPX ETF, focused on high-growth IPOs, may not be the best investment choice in a high-interest rate environment. Read an ...
BioPharma Ltd. (NASDAQ: QNTM), a biopharmaceutical company with a market capitalization of $16.86 million, announced that Celly Nutrition Corporation, the creator of the beverage unbuzzdTM, has taken ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback